Include men in clinical trials for breast cancer, stresses FDA in a draft guidance Medha Baranwal Baranwal27 Aug 2019 7:25 PM ISTUSA: The U.S. Food and Drug Administration has stressed the inclusion of male patients in the clinical trials of breast cancer, in a recently released...
Liraglutide linked with increased risk of gallbladder or biliary tract related events, finds study Deepanjana Sarkar28 Aug 2019 8:28 PM ISTType 2 diabetes drug Liraglutide linked with increased risk of gallbladder or biliary tract related events, revealed a study published in the Journal...
FDA warning: Hepatitis C drugs causing rare liver injury in patients with liver disease Medha Baranwal Baranwal29 Aug 2019 7:15 PM ISTSome drugs used for the treatment of chronic hepatitis C (HCV) may cause serious liver injury or failure in some patients with advanced liver disease,...
FDA clears 14-Day version of ambulatory cardiac patch monitoring Dr. Kamal Kant Kohli Kohli8 Sept 2019 7:28 PM ISTFood and Drug Administration has granted clearance to the 14-Day version of the Carnation Ambulatory Monitor ("CAM™"), the industry's only P-wave...
AAC releases new guidance on Intra-articular injections for knee osteoarthritis Hina Zahid16 Sept 2019 7:00 PM ISTArthroscopy Association of Canada has released a position statement on Intra-articular Injections for Knee osteoarthritis. A key component of...
FDA grants clearance to smart, robotic external fixation system for orthopedic treatments Hina Zahid19 Sept 2019 7:05 PM ISTThe United States Food and Drug Administration (FDA) has given regulatory clearance to smart, robotic external fixation system for orthopedic...
FDA approves first ever oral Semaglutide for blood sugar control in type 2 diabetes Dr. Kamal Kant Kohli Kohli20 Sept 2019 8:20 PM ISTFood and Drug Administration has approved first GLP-1 oral drug Semaglutide for blood sugar control in type 2 diabetes.The U.S. Food and Drug...
FDA approves new treatment for hepatitis C virus and compensated cirrhosis Medha Baranwal Baranwal26 Sept 2019 7:05 PM ISTUSA: Mavyret (glecaprevir and pibrentasvir) tablets have received FDA's approval for an eight-week duration for the treatment of adults and children...
Anti-malarial drug quinacrine effective for treatment of head and neck cancer Hina Zahid2 Oct 2019 7:15 PM ISTBirmingham, UK: Quinacrine, an anti-malarial drug, can make standard chemotherapy for the treatment of neck and head cancer more effective -- is the...
FDA grants clearance to new Blood Flow Monitoring Device for peripheral artery disease Dr. Kamal Kant Kohli Kohli3 Oct 2019 7:28 PM IST A new blood flow monitoring device, FlowMet-R, has received clearance from the Food and Drug Administration (FDA). This clearance allows Laser...
New Acne cream Clascoterone under review of FDA Hina Zahid12 Nov 2019 7:15 PM ISTThe Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for clascoterone cream 1% for the treatment of acne....
FDA Panel votes in favour of Teprotumumab for Thyroid Eye Disease Hina Zahid17 Dec 2019 7:05 PM ISTA US Food and Drug Administration (FDA) advisory panel has voted in favour of the approval of teprotumumab solution for intravenous use(Horizon...
